Sharon L. Reed

Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics

Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission

Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019

Cysteine proteases in protozoan parasites

Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy

Point‐of‐care diagnosis of invasive aspergillosis in non‐neutropenic patients: <i>Aspergillus</i> Galactomannan Lateral Flow Assay versus <i>Aspergillus</i>‐specific Lateral Flow Device test in bronchoalveolar lavage

Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignancies

Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease Epidemiology

Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection

Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens

Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent

X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action

New drug target in protozoan parasites: the role of thioredoxin reductase

A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia

Reprofiled drug targets ancient protozoans

A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target

Human milk oligosaccharides reduce<i>Entamoeba histolytica</i>attachment and cytotoxicity<i>in vitro</i>